FindTrial
Sign In

Prognostic Prediction of Hepatocellular Carcinoma Invasiveness Based on CEMRI Combined Habitat Analysis

Prognostic Prediction of Hepatocellular Carcinoma Invasiveness Based on CEMRI Combined Habitat Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124950
Enrollment
Unknown
Registered
2026-05-19
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Test set & Training set & Validation set:None

Sponsors

Chengdu Qingyang District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with pathological results confirming HCC and who have completed MVI assessment; 2.HCC patients without recurrence; 3.Underwent abdominal MRI examination within 2 weeks before surgery; 4.Have not received local or systemic anti-tumor treatment before surgery; 5.No comorbidity with other malignant tumors.

Exclusion criteria

Exclusion criteria: 1.Poor image quality caused by respiratory motion artifacts, evaluated by a senior abdominal radiologist; 2.HCC-related treatments before CEMRI scanning, such as radiofrequency ablation or transarterial chemoembolization; 3.Unresectable HCC; 4.No MVI or tumor differentiation report.

Design outcomes

Primary

MeasureTime frame
MRI indicators;—

Countries

China

Contacts

Public ContactFeng Han

Chengdu Qingyang District Traditional Chinese Medicine Hospital

840926802@qq.com+86 28 69282120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026